• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性结外淋巴瘤患者的预后分析:一项回顾性研究

Prognostic Analysis of Patients with Primary Extranodal Lymphoma: A Retrospective Study.

作者信息

Shen Hanying, Jiang Lingling, Nie Linlin, Fan Xiaohui, Xu Yanqiu, Yin Lingling, Xu Linyan, Xia Jieyun, Li Zhenyu, Zhu Feng, Xu Kailin

机构信息

Blood Disease Institute, Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People's Republic of China.

Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People's Republic of China.

出版信息

Cancer Manag Res. 2021 Mar 2;13:2171-2180. doi: 10.2147/CMAR.S299745. eCollection 2021.

DOI:10.2147/CMAR.S299745
PMID:33688260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7936719/
Abstract

BACKGROUND

Originating from extranodal organs or tissues, primary extranodal lymphoma (PENL) acts in different primary sites with diverse clinical performances and PENL has remarkable geographical differences and lacks the relevant reports in each region.

PATIENTS AND METHODS

Two hundred and twenty PENL patients were enrolled, and the relevant clinical and laboratory indicators were analyzed. In addition, statistical methods were applied to analyze the effects of different factors on overall survival (OS) and progression-free survival (PFS) of patients.

RESULTS

The three most frequent primary sites of PENL are the digestive system, head and neck, and central nervous system. The patients were classified into groups based on their risk status, resulting in low-risk, medium-low-risk, medium-high-risk, and high-risk, and their respective 3-year OS values were calculated, which showed that 121 patients (55%) were in the low-risk group and 3-year OS was 85.2% (25.9% medium-low-risk, 3-year OS 66.6%; 15% medium-high-risk, 3-year OS 61.9%; 4.09% high risk, 3-year OS 45.7%). A multivariate analysis of the Cox regression demonstrated that serum beta 2-microglobulin (β-MG) and lactate dehydrogenase (LDH) were independent prognostic factors for OS and PFS, respectively. Both the performance status and pathological subtypes were independent prognostic factors for OS and PFS.

CONCLUSION

The correlated independent risk factors such as β-MG, LDH, performance status, and pathological subtypes, were helpful for effectively determining the prognosis of PENL patients and guiding treatment.

摘要

背景

原发性结外淋巴瘤(PENL)起源于结外器官或组织,在不同的原发部位表现各异,具有显著的地域差异,且各地区缺乏相关报道。

患者与方法

纳入220例PENL患者,分析相关临床和实验室指标。此外,应用统计学方法分析不同因素对患者总生存期(OS)和无进展生存期(PFS)的影响。

结果

PENL最常见的三个原发部位是消化系统、头颈部和中枢神经系统。根据患者的风险状态进行分组,分为低风险、中低风险、中高风险和高风险组,并计算各自的3年OS值,结果显示121例患者(55%)处于低风险组,3年OS为85.2%(中低风险组25.9%,3年OS为66.6%;中高风险组15%,3年OS为61.9%;高风险组4.09%,3年OS为45.7%)。Cox回归多因素分析表明,血清β2-微球蛋白(β-MG)和乳酸脱氢酶(LDH)分别是OS和PFS的独立预后因素。体能状态和病理亚型均是OS和PFS的独立预后因素。

结论

β-MG、LDH、体能状态和病理亚型等相关独立危险因素有助于有效判断PENL患者的预后并指导治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/9441f0190609/CMAR-13-2171-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/42b0fbbb1c82/CMAR-13-2171-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/cabcb41fce9d/CMAR-13-2171-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/e51ecc67d925/CMAR-13-2171-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/0c22259de6b8/CMAR-13-2171-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/9441f0190609/CMAR-13-2171-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/42b0fbbb1c82/CMAR-13-2171-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/cabcb41fce9d/CMAR-13-2171-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/e51ecc67d925/CMAR-13-2171-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/0c22259de6b8/CMAR-13-2171-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1972/7936719/9441f0190609/CMAR-13-2171-g0005.jpg

相似文献

1
Prognostic Analysis of Patients with Primary Extranodal Lymphoma: A Retrospective Study.原发性结外淋巴瘤患者的预后分析:一项回顾性研究
Cancer Manag Res. 2021 Mar 2;13:2171-2180. doi: 10.2147/CMAR.S299745. eCollection 2021.
2
Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.国际预后指数在中国非霍奇金淋巴瘤患者及原发性结外淋巴瘤高发病率研究中的应用。
Cancer. 1998 Jun 15;82(12):2439-48. doi: 10.1002/(sici)1097-0142(19980615)82:12<2439::aid-cncr19>3.0.co;2-q.
3
[Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].[110例原发性胃肠道弥漫大B细胞淋巴瘤不同分期系统评估及预后分析]
Zhonghua Yi Xue Za Zhi. 2019 Jun 25;99(24):1853-1858. doi: 10.3760/cma.j.issn.0376-2491.2019.24.004.
4
Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.原发部位和区域淋巴结受累是早期结外鼻型自然杀伤/T细胞淋巴瘤的独立预后因素。
Chin J Cancer. 2016 Apr 4;35:34. doi: 10.1186/s40880-016-0096-0.
5
The role of surgical management in primary small bowel lymphoma: A single-center experience.手术治疗在原发性小肠淋巴瘤中的作用:单中心经验
Eur J Surg Oncol. 2017 Oct;43(10):1886-1893. doi: 10.1016/j.ejso.2017.06.016. Epub 2017 Jul 18.
6
[Clinical and pathological analysis of 236 patients with primary extranodal lymphoma].236例原发性结外淋巴瘤患者的临床病理分析
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):85-92. doi: 10.7534/j.issn.1009-2137.2014.01.018.
7
Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma.外周 T 细胞淋巴瘤患者的临床特征与预后分析。
Medicine (Baltimore). 2021 Apr 2;100(13):e25194. doi: 10.1097/MD.0000000000025194.
8
A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels.基于黏膜相关淋巴组织国际预后指数和血清β2-微球蛋白水平的结外边缘区淋巴瘤预后指数。
Br J Haematol. 2021 Apr;193(2):307-315. doi: 10.1111/bjh.17222. Epub 2020 Nov 20.
9
CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.CD56阴性的结外NK/T细胞淋巴瘤应被视为一种预后较差的独特亚型。
Tumour Biol. 2015 Sep;36(10):7717-23. doi: 10.1007/s13277-015-3485-0. Epub 2015 May 3.
10
Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.血清β2-微球蛋白可预测上呼吸消化道 NK/T 细胞淋巴瘤患者的预后。
Ann Hematol. 2012 Aug;91(8):1265-70. doi: 10.1007/s00277-012-1434-1. Epub 2012 Feb 29.

本文引用的文献

1
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).包含绝对淋巴细胞/单核细胞比值、红细胞分布宽度和β-2 微球蛋白的新预后评分在接受 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者中的应用:西班牙淋巴瘤组经验(GELTAMO)。
Br J Haematol. 2020 Mar;188(6):888-897. doi: 10.1111/bjh.16263. Epub 2019 Nov 28.
2
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.NCCN 指南解读:B 细胞淋巴瘤,第 3.2019 版。
J Natl Compr Canc Netw. 2019 Jun 1;17(6):650-661. doi: 10.6004/jnccn.2019.0029.
3
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.
NCCN 指南解读:T 细胞淋巴瘤,第 2.2018 版。
J Natl Compr Canc Netw. 2018 Feb;16(2):123-135. doi: 10.6004/jnccn.2018.0007.
4
Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice.Trf1和/或Tin2的基因剂量减少会在衰老小鼠中诱导端粒DNA损伤和淋巴瘤形成。
Leukemia. 2017 Dec;31(12):2853. doi: 10.1038/leu.2017.224. Epub 2017 Nov 10.
5
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.利妥昔单抗时代弥漫性大B细胞淋巴瘤患者血清β2微球蛋白的预后意义
Oncotarget. 2016 Nov 22;7(47):76934-76943. doi: 10.18632/oncotarget.12734.
6
Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: a Population-Based Survival Analysis.原发性胃肠道非霍奇金淋巴瘤的管理:一项基于人群的生存分析
J Gastrointest Surg. 2016 Jun;20(6):1141-9. doi: 10.1007/s11605-016-3129-8. Epub 2016 Mar 18.
7
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.恶性淋巴瘤中可溶性白细胞介素-2受体和血清乳酸脱氢酶的评估。
Ann Hematol. 2015 Nov;94(11):1935-7. doi: 10.1007/s00277-015-2448-2. Epub 2015 Jul 25.
8
The biology of aging and lymphoma: a complex interplay.衰老与淋巴瘤的生物学:复杂的相互作用。
Curr Oncol Rep. 2015 Jul;17(7):32. doi: 10.1007/s11912-015-0457-x.
9
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.霍奇金淋巴瘤和非霍奇金淋巴瘤初始评估、分期及反应评估的建议:卢加诺分类
J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800.
10
[Clinical and pathological analysis of 236 patients with primary extranodal lymphoma].236例原发性结外淋巴瘤患者的临床病理分析
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):85-92. doi: 10.7534/j.issn.1009-2137.2014.01.018.